Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
The Journal of Antimicrobial Chemotherapy|October 1, 1989
Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniaeD Sirot, C Chanal, R Labia, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospitalC Chanal, R Bonnet, C De Champs, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytocaD Sirot, R Labia, P Pouedras, et al.
Biochimica Et Biophysica Acta|March 21, 1998
Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modellingE B Chaibi, J Péduzzi, S Farzaneh, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1997
Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamasesM M Caniça, M Barthélémy, L Gilly, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
SHV-16, a beta-lactamase with a pentapeptide duplication in the omega loopC Arpin, R Labia, C Andre, et al.
Drugs|January 1, 1986
Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial speciesR Labia, M Barthelemy, C B Le Bouguennec, et al.
Antimicrobial Agents and Chemotherapy|February 27, 1999
Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron geneL Poirel, T Naas, M Guibert, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Diversity of TEM mutants in Proteus mirabilisR Bonnet, C De Champs, D Sirot, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothinC Chanal-Claris, D Sirot, L Bret, et al.
Pageof 18